Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL156437 | 1.00 | TDP1 (0.50) | TDP1ALDH1A1LMNAMAPK1CYP3A4 | |
| Amiloxate SCHEMBL5827367 | 0.87 | TDP1 (0.59) | TDP1ALDH1A1LMNAMAPK1CYP3A4 | |
| SCHEMBL31329227 | 0.85 | TDP1 (0.50) | TDP1ALDH1A1LMNAMAPK1CYP3A4 | |
| SCHEMBL3762224 | 0.83 | TDP1 (0.53) | TDP1ALDH1A1LMNAMAPK1CYP3A4 | |
| SCHEMBL2692264 | 0.83 | APP (0.45) | ALDH1A1LMNATSHRKDM4EHDAC8 | |
| SCHEMBL29000086 | 0.83 | TDP1 (0.56) | TDP1ALDH1A1LMNAMAPK1CYP3A4 | |
| SCHEMBL29000084 | 0.83 | TDP1 (0.56) | TDP1ALDH1A1LMNAMAPK1CYP3A4 | |
| SCHEMBL39304 | 0.82 | ALDH1A1 (0.48) | ALDH1A1LMNACYP3A4CA2KDM4E | |
| SCHEMBL39303 | 0.82 | ALDH1A1 (0.48) | ALDH1A1LMNACYP3A4CA2KDM4E | |
| SCHEMBL5494926 | 0.82 | PTGER1 (0.37) | ALDH1A1KDM4EHDAC8CTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9011826-B2 | Cosmetic and dermatological formulations including isononyl benzoate | EVONIK DEGUSSA GMBH (DE) | 2015-04-21 | — | — | US | claimed |
| US-8748347-B2 | Method for combating harmful fungi | BASF SE (DE) | 2014-06-10 | — | — | US | claimed |
| US-20120083497-A1 | Method for Combating Harmful Fungi | BASF SE (DE) | 2012-04-05 | — | — | US | claimed |
| WO-2010115721-A2 | METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS | BASF SE (DE) | 2010-10-14 | — | — | WO | claimed |
| WO-2010115720-A2 | METHOD FOR COMBATING HARMFUL FUNGI | BASF SE (DE) | 2010-10-14 | — | — | WO | claimed |
| US-20100068160-A1 | COSMETIC AND DERMATOLOGICAL FORMULATIONS INCLUDING PHENOXYALKYL ESTERS | EVONIK GOLDSCHMIDT GMBH (DE) | 2010-03-18 | — | — | US | claimed |
| US-20090136437-A1 | COSMETIC AND DERMATOLOGICAL FORMULATIONS INCLUDING ISONONYL BENZOATE | EVONIK GOLDSCHMIDT GMBH (DE) | 2009-05-28 | — | — | US | claimed |
| US-20080171004-A1 | Using compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, such as 4-hydroxyphenylpropionic acid, or 2-ethylhexyl 4-hydroxy-3,5-dimethoxycinnamate, or polysiloxanes which contain benzylidenemalonic acid derivatives | MERCK PATENT GMBH (DE) | 2008-07-17 | — | — | US | claimed |
| US-7258923-B2 | Multilayered articles and method of manufacture thereof | GENERAL ELECTRIC COMPANY (US) | 2007-08-21 | — | — | US | claimed |
| US-20250375369-A1 | COMPOSITIONS COMPRISING SELF TANNING AGENTS AND CERTAIN SPHINGOLIPIDS AND/OR CERTAIN SPHINGOID BASES | EVONIK OPERATIONS GMBH (DE) | 2025-12-11 | — | — | US | disclosed |
| US-20250248394-A1 | HERBICIDAL EODE FORMULATION COMPRISING SEVERAL ACTIVE INGREDIENTS | BASF Agro B.V. (NL) | 2025-08-07 | — | — | US | disclosed |
| EP-4547204-A1 | COMPOSITIONS COMPRISING SELF TANNING AGENTS AND CERTAIN SPHINGOLIPIDS AND/OR CERTAIN SPHINGOID BASES | Evonik Operations GmbH (DE) | 2025-05-07 | — | — | EP | disclosed |
| CN-119677493-A | Compositions comprising a self-tanning agent and certain sphingolipids and/or certain sphingosine bases | 赢创运营有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2024126115-A1 | AGROCHEMICAL FORMULATIONS | BASF SE (DE) | 2024-06-20 | — | — | WO | disclosed |
| EP-0908501-B1 | Reversible thermochromic composition | PILOT INK CO LTD (JP) | 2003-07-09 | — | — | EP | disclosed |
| US-20030121448-A1 | Reversible thermochromic composition | NEW PRISMATIC ENTERPRISE CO., LTD. (TW) | 2003-07-03 | — | — | US | disclosed |
| US-6572663-B1 | Providing aqueous surface-active fatty alcohol dispersion containing fatty alcohol and surfactant, stirring with oil component and hair dye component at temperature of from 18 to 25 degrees C., to form hair dye preparation | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2003-06-03 | — | — | US | disclosed |
| US-20010046507-A1 | Cosmetic and pharmaceutical oil-in-water emulsions | GOLDSCHMIDT AG (DE) | 2001-11-29 | — | — | US | disclosed |
| US-6048387-A | SPECIFIED DIAZARHODAMINE LACTONE DERIVATIVE AS AN ELECTRON-DONATING COLOR-DEVELOPING ORGANIC COMPOUND | THE PILOT INK CO., LTD. (JP) | 2000-04-11 | — | — | US | disclosed |
| EP-0908501-A1 | Reversible thermochromic composition | THE PILOT INK CO., LTD. (JP) | 1999-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171004-A1 | Using compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, such as 4-hydroxyphenylpropionic acid, or 2-ethylhexyl 4-hydroxy-3,5-dimethoxycinnamate, or polysiloxanes which contain benzylidenemalonic acid derivatives | HPD, HAAO, UGT1A6 | TDP1 2793/4885ALDH1A1 314/4885LMNA 565/4885 |
| US-20090136437-A1 | COSMETIC AND DERMATOLOGICAL FORMULATIONS INCLUDING ISONONYL BENZOATE | C1R, POLR1C, C1S | TDP1 314/4885ALDH1A1 510/4885LMNA 1388/4885 |
| US-20250375369-A1 | COMPOSITIONS COMPRISING SELF TANNING AGENTS AND CERTAIN SPHINGOLIPIDS AND/OR CERTAIN SPHINGOID BASES | DEGS1, UGCG, SMPD1 | TDP1 48/4885ALDH1A1 3089/4885LMNA 1320/4885 |
| US-20100068160-A1 | COSMETIC AND DERMATOLOGICAL FORMULATIONS INCLUDING PHENOXYALKYL ESTERS | CUTA, DECR2, TYR | TDP1 3701/4885ALDH1A1 419/4885LMNA 1413/4885 |
| US-20120083497-A1 | Method for Combating Harmful Fungi | BROX, CRY1, GUSB | TDP1 1494/4885ALDH1A1 2453/4885LMNA 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.